Health System | Glytec

September 12, 2019

WellStar Health System Expands Use of Glytec’s eGlycemic Management System®

Georgia’s largest health system is heightening the safety and efficacy of insulin therapy across its network of hospitals.

Known nationally for innovative care models, WellStar Health System, in partnership with Glytec, is taking proactive measures to optimize glycemic management for hospitalized patients. The not-for-profit health system is expanding use of Glytec’s patented and FDA-cleared eGlycemic Management System® (eGMS®) beyond its two largest facilities, WellStar Kennestone Hospital and WellStar Atlanta Medical Center, to an additional eight facilities in the Greater Atlanta and surrounding area.

July 30, 2019

Northeast Georgia Medical Center to Implement eGlycemic Management System® from Glytec

The not-for-profit community medical center is partnering with Glytec to facilitate standardization of best practices in diabetes therapy management.

With as many as half of critical care patients either diagnosed with diabetes or at risk of hyperglycemia while hospitalized, Northeast Georgia Medical Center, in partnership with Glytec, is taking advanced measures to optimize glycemic management and ensure the safety and efficacy of insulin therapy. “Our organization is steadfastly committed to clinical excellence in diabetes care and glycemic management,” says Dr. Suhel Patel, Medical Director and Chair, Inpatient Medicine, Northeast Georgia Physicians Group. “By adopting the Glytec suite of technologies and services, our patients will receive insulin therapy that is personalized to their individual needs and carefully designed to support their recovery and transitions of care.”

April 30, 2019

Metro Health – University of Michigan Health to Use Glytec’s Software for Inpatient Diabetes Care

The Wyoming, Michigan-based healthcare organization will partner with Glytec to provide patients an integrated model of technology-enabled glycemic management.

Known for high-quality, personalized care and award-winning services, Metro Health – University of Michigan Health is taking inpatient diabetes management to the next level. With a decades-long focus on ensuring glucose control is a top priority, the healthcare organization has selected Glytec’s eGlycemic Management System® (eGMS®) to advance the standardization of best practice. The software-as-a-medical-device eGMS® platform is both patented and FDA cleared.

January 15, 2019

At a Cost of $10,405 Per Patient Stay, Hypoglycemia in The Hospital Cannot Be Ignored

A diabetes webinar hosted by the American Hospital Association and sponsored by Glytec showcased why hypoglycemia prevention is imperative to the safety of patients and to the economics of healthcare delivery.

Featured speakers, Dr. Richard Pratley of Florida Hospital System and Dr. Steven Edelman of UC San Diego Health, recently delivered a unified message to several hundred senior healthcare professionals attending an American Hospital Association webinar: Hypoglycemia [low blood sugar] in the hospital is a major patient safety risk with significant clinical and financial implications. A case study presented by Pratley further revealed that insulin-managed patients who experience severe hypoglycemia, or blood sugar less than 40 mg/dL, have longer stays, higher readmission and mortality rates, and an overall cost of care $10,405 greater than patients whose blood sugar remains in the normal range.

November 8, 2018

Novant Health Goes Live With Glytec’s eGlycemic Management System®

The 14-hospital health system implements Glytec’s insulin therapy optimization solution and achieves rapid, broad-based adoption of basal-bolus best practice.

Novant Health has successfully partnered with Glytec to achieve best practice for insulin therapy in accordance with American Diabetes Association (ADA) and American Association of Clinical Endocrinologists (AACE) guidelines. Through a combination of Glytec’s FDA-cleared eGlycemic Management System® (eGMS®) and expert clinical change management program, Novant Health of Winston-Salem, North Carolina has now transitioned from manual, paper-based protocols for sliding-scale insulin therapy to fully integrated, computer-guided decision support for basal-bolus insulin therapy.

November 1, 2018

Adventist Health System Deploys Glytec’s eGlycemic Management System®

Nearly three dozen AHS acute care facilities are live with Glytec’s software for intravenous insulin optimization.

Adventist Health System (AHS), one of the largest faith-based health systems in the U.S., has successfully deployed the eGlycemic Management System® from Glytec. As a result, 33 AHS acute care facilities across seven states are now utilizing Glytec’s solution for intravenous insulin optimization.

June 29, 2018

Major Academic Health System Taps Glytec for Insulin Management Technology

Duke University Health System has selected Glytec’s eGlycemic Management System® to elevate the quality and safety of care for patients with diabetes and others who require insulin therapy.

With national statistics indicating that one of every three hospitalized patients requires insulin therapy during their stay, administering the right dose at the right time in accordance with best practices is integral to safe, effective care and speedy recovery. By implementing Glytec’s FDA-cleared eGlycemic Management System® (eGMS®) for personalized medication optimization, Duke Regional Hospital of Durham, North Carolina is equipping its staff with a proven and highly efficient means to individualize and standardize insulin therapy. Among the key benefits of eGMS® are helping prevent hypoglycemia and hyperglycemia while also rapidly achieving and maintaining glycemic targets and reducing length of stay.

March 20, 2018

Piedmont Healthcare Expands Use of Glytec’s Software for Insulin Therapy Management

Atlanta-based Piedmont Healthcare will implement Glytec’s eGlycemic Management System® across all acute care facilities.

Standardizing and personalizing insulin therapy management for hospitalized patients is a goal Piedmont Healthcare is poised to achieve through expanded use of Glytec’s eGlycemic Management System®, or eGMS®. The not-for-profit healthcare system currently uses eGMS® at Piedmont Atlanta Hospital, Piedmont Newnan Hospital and Piedmont Athens Regional Medical Center. Based on a new agreement, Piedmont Healthcare will implement eGMS® at Piedmont Henry Hospital, Piedmont Fayette Hospital, Piedmont Newton Hospital and Piedmont Mountainside Hospital.

December 5, 2017

Chesapeake Regional Healthcare will Implement Glytec’s Software to Bolster High-Reliability Care

Glytec’s eGlycemic Management System® will ensure clinicians have ready access to evidence-based decision support for personalized insulin therapy management.

Fostering a culture of patient safety is integral to the care Chesapeake Regional Healthcare delivers, and a new partnership with Glytec will enable best practices in glycemic management across all inpatient service lines. Glytec’s eGlycemic Management System® will support the optimization of intravenous and subcutaneous insulin therapy during hospitalization, and will provide evidence-based guidance on transitions in insulin therapy from hospital to home.

October 17, 2017

Adventist Health System Partners With Glytec to Enhance Diabetes Care

The health system will utilize Glytec’s eGlycemic Management System® at 39 of its acute care facilities.

More than a quarter of all hospitalized patients in the U.S. have diabetes, and typically, these patients stay longer, experience more infections and have higher readmission rates.* Recognizing the unique challenges of caring for patients with diabetes, Adventist Health System, one of the largest faith-based health systems in the U.S., has partnered with Glytec, a leader in diabetes therapy management software and medication optimization, to implement the eGlycemic Management System® (eGMS®) at 39 of its acute care facilities.

June 7, 2017

Case Studies Presented at Diabetes Technology Society Conference Highlight Millions in Hospital Cost Savings with Improved Glucose Control

One study presented at the International Hospital Diabetes Meeting observed first-year cost savings of nearly $7.5 million stemming from adoption of best practice for insulin therapy.

A series of studies and presentations included in the 6th International Hospital Diabetes Meeting highlighted the high cost of poor glucose management, and in particular, severe hypoglycemia (< 40 mg/dL) in the acute care setting. With thirty to forty percent of ALL hospitalized patients requiring insulin therapy, not just those with diabetes, the common problem of insulin mismanagement has significant impact on care quality, patient safety and patient experience, as well as cost and value.

March 10, 2017

Taking Insulin e-Therapy to Heart

Cardiovascular (CVD) patients receiving personalized insulin therapy using a software-based hyperglycemia management program had dramatically fewer hospital readmissions than those given standard care, according to two studies from Mountain States Health Alliance health care system.

The retrospective studies focused on readmission rates for three patient populations admitted for CVD indications between January and December 2015. The results showed that compared with patients treated with standard care, coronary artery bypass graft patients were readmitted 68% less often with the software program; congestive heart failure patients were readmitted 65% less often; and acute myocardial infarction patients were readmitted 36% less often, the investigators reported at the 2016 Annual Diabetes Technology Meeting.

February 7, 2017

Novant Health Partners with Glytec to Advance Leadership Position in Patient-Centered Diabetes Care

Glytec’s solution will enable the 14-hospital health system to achieve best practice, reduce variability and standardize care for patients with diabetes.

Becoming a national leader in diabetes care is a commitment Novant Health, headquartered in Winston-Salem, North Carolina, will advance through a new partnership with Glytec. The company’s patented eGlycemic Management System® (eGMS®) will be a focal point of the health system’s diabetes service line, offering clinicians a comprehensive set of tools, technologies and processes proven to achieve full adoption of basal-bolus insulin therapy, the standard of care and best practice endorsed by the American Diabetes Association (ADA) and American Association of Clinical Endocrinologists (AACE).

January 25, 2017

Grady Health System Improves Diabetes Care With Glytec’s eGlycemic Management System

Glytec’s system for personalized diabetes therapy management translates to better quality of care at Atlanta’s Grady Health System.

In its quest to ensure high quality care for critically ill patients, Atlanta’s Grady Health System has implemented the evidence-based Glytec eGlycemic Management System® (eGMS®), a personalized diabetes therapy management solution.

December 20, 2016

Digital Insulin Management Cuts Hospital Readmissions for CV Patients

The findings come as CMS targets cardiac procedures in both its hospital readmission reduction program and in a bundled payment model set to take effect July 1, 2017.

Glytec, which has FDA clearance for a cloud-based system to manage insulin dosing, selected MSHA as a research site for its electronic glucose management system, or eGMS. According to the studies Parsons and Mumpower presented in November at the Diabetes Technology Meeting showcase, eGMS produced sharp drops in readmission rates in 3 areas of cardiac care.

November 14, 2016

Dramatic Readmission Reductions for CABG, CHF and AMI Attributed to Glytec’s eGlycemic Management System

Two studies presented at the 16th Annual Diabetes Technology Meeting showcase readmission reductions as high as 68% with Glytec’s solution.

Two new studies presented at last week’s Diabetes Technology Meeting further validate the ability of Glytec’s eGlycemic Management System® (eGMS®) to achieve dramatic readmission reductions for patient populations at the center of new at-risk and value-based reimbursement models, including the CMS Hospital Readmission Reduction Program (HRRP) and impending bundled payment for coronary artery bypass graft surgery (CABG).

October 5, 2016

CHI Franciscan Updating Glucose Management Tools, Seeking Robust EHR Integration

CHI Franciscan Health is preparing to implement a new SaaS-based glucose management system that offers proprietary insulin dosing algorithms, analytics and reporting, automated surveillance and alerting, but the real selling point was more seamless EHR integration.

The perceived value of medical devices and ancillary software systems is increasingly tied to how seamlessly they integrate with EHR platforms from Epic or Cerner. That was the case when CHI Franciscan Health in Tacoma, Wash., recently evaluated glucose management systems. One key reason the eight-hospital system chose to implement Glytec’s eGlycemic Management System (eGMS) was its robust integration with Epic.

September 30, 2016

Hawaii Pacific Health Receives 2016 HIMSS Enterprise Davies Award Based in Part on Success With Glytec’s eGMS®

Our client, Hawaii Pacific Health, was named a HIMSS Enterprise Davies Award recipient based in part on its success implementing Glytec’s eGlycemic Management System® to support computer-based insulin dosing and a new hypoglycemia protocol.

The results were better glucose control with computer-directed insulin dosing system versus usual care. 39.8% of all glucose values in the ICU setting were above the recommended limit (glucose 180 mg/dl) with usual care. With computer-directed insulin dosing system for intravenous insulin, the hyperglycemia rate was much lower representing just 16.6% of all glucose values.

September 22, 2016

CHI Franciscan Health Selects Glytec’s eGMS® for Precision Diabetes Management

The eGMS® solution suite includes real-time insulin dosing, robust analytics and reporting, automated surveillance and alerting, clinical transformation services, and more.

CHI Franciscan Health of Tacoma, Washington has recently turned to Glytec for its comprehensive eGlycemic Management System®, or eGMS®, which includes FDA-cleared technology for both intravenous and subcutaneous real-time insulin dosing.

September 13, 2016

Palmetto Health to Use Glytec’s eGlycemic Management System® for Diabetes Care

The FDA-cleared technology solution will help facilitate best practices for glycemic management across the integrated health care system.

Palmetto Health, the largest integrated health care system in the South Carolina Midlands region, has selected Glytec’s eGlycemic Management System®, or eGMS®, to support quality of care for patients with diabetes. The cloud-hosted eGMS® software-as-a-service (SaaS) solution will be used enterprise-wide, across all of Palmetto Health’s clinical disciplines.

Page 1 of 2
1
2
→